Yarrow Bioscience, Inc. Common Stock reported earnings of -$ 0.43 per YARW share on Nov 12, 2026, falling short of analysts' expectations by
| Report Date | Nov 12, 2026 |
|---|---|
| Forecasted EPS | -$ 0.71 |
| Earnings Per Share (Surprise) | -$ 0.43 (+$ 0.28) |
| Last Year's EPS | -$ 2.34 |
| EPS YoY Change |
Out of the last 42 earnings reporting periods, Yarrow Bioscience, Inc. Common Stock beat analysts’ expectations 24 times and fell short of expectations 12 time(s). Yarrow Bioscience, Inc. Common Stock reported earnings per share of -$ 0.43 in the last report surpassing an estimated EPS of -$ 0.71 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.71 | -$ 0.43 | -$ 2.50 | |
| Aug 13, 2026 | -$ 11.00 | -$ 2.14 | -$ 0.17 | |
| May 15, 2026 | -$ 9.00 | -$ 4.00 | -$ 6.50 | |
| May 14, 2026 | -$ 9.00 | -$ 32.50 | -$ 0.20 | |
| Mar 12, 2026 | -$ 0.10 | -$ 2.50 | -$ 0.28 | |
| Nov 6, 2025 | -$ 0.19 | -$ 0.17 | -$ 0.29 | |
| Aug 14, 2025 | -$ 0.23 | -$ 6.50 | -$ 11.00 | |
| May 8, 2025 | -$ 0.29 | -$ 0.20 | -$ 7.50 | |
| Mar 6, 2025 | -$ 12.50 | -$ 0.28 | -$ 9.00 | |
| Nov 7, 2024 | -$ 11.50 | -$ 0.29 | -$ 1.85 | |
| Aug 14, 2024 | -$ 9.50 | -$ 11.00 | -$ 3.08 | |
| May 9, 2024 | -$ 12.00 | -$ 7.50 | -$ 1.74 | |
| Feb 29, 2024 | -$ 25.00 | -$ 9.00 | -$ 2.60 | |
| Nov 13, 2023 | -$ 38.00 | -$ 1.85 | -$ 1.44 | |
| Aug 14, 2023 | -$ 99.50 | -$ 3.08 | -$ 2.34 | |
| May 11, 2023 | -$ 130.50 | -$ 1.74 | -$ 2.52 | |
| Mar 9, 2023 | -$ 162.00 | -$ 2.60 | -$ 1.80 | |
| Nov 10, 2022 | -$ 0.03 | -$ 1.44 | -$ 6.47 | |
| Aug 12, 2022 | -$ 3.11 | -$ 2.34 | -$ 6.29 | |
| May 12, 2022 | -$ 144.00 | -$ 2.52 | -$ 6.65 |
Yarrow Bioscience, Inc. Common Stock’s stock was trading at $ 18.05 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, YARW’s price decreased to $ 18.03 on Nov 13, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.43 | $ 18.05 | $ 18.03 | |
| Aug 13, 2026 | -$ 2.14 | $ 42.77 | $ 42.49 | |
| May 15, 2026 | -$ 4.00 | $ 33.52 | $ 33.82 | |
| May 14, 2026 | -$ 32.50 | $ 33.50 | $ 33.50 | |
| Mar 12, 2026 | -$ 2.50 | $ 30.00 | $ 29.57 | |
| Nov 6, 2025 | -$ 0.17 | $ 16.90 | $ 17.62 | |
| Aug 14, 2025 | -$ 6.50 | $ 17.38 | $ 17.54 | |
| May 8, 2025 | -$ 0.20 | $ 68.50 | $ 65.00 | |
| Mar 6, 2025 | -$ 0.28 | $ 119.50 | $ 109.50 | |
| Nov 7, 2024 | -$ 0.29 | $ 156.50 | $ 158.00 | |
| Aug 14, 2024 | -$ 11.00 | $ 85.50 | $ 93.00 | |
| May 9, 2024 | -$ 7.50 | $ 136.00 | $ 133.50 | |
| Feb 29, 2024 | -$ 9.00 | $ 116.50 | $ 111.00 | |
| Nov 13, 2023 | -$ 1.85 | $ 175.50 | $ 178.50 | |
| Aug 14, 2023 | -$ 3.08 | $ 275.00 | $ 242.50 | |
| May 11, 2023 | -$ 1.74 | $ 299.00 | $ 361.50 | |
| Mar 9, 2023 | -$ 2.60 | $ 153.00 | $ 130.50 | |
| Nov 10, 2022 | -$ 1.44 | $ 221.50 | $ 243.00 | |
| Aug 12, 2022 | -$ 2.34 | $ 273.50 | $ 288.00 | |
| May 12, 2022 | -$ 2.52 | $ 341.00 | $ 358.00 |
Yarrow Bioscience, Inc. Common Stock released its most recent earnings reports in November 2026, August 2026, May 2026, May 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Yarrow Bioscience, Inc. Common Stock beat analysts’ expectations during the last earnings period by
